These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7779651)

  • 21. Can menopause be considered an independent risk factor for cardiovascular disease?
    Mercuro G; Zoncu S; Cherchi A; Rosano GM
    Ital Heart J; 2001 Oct; 2(10):719-27. PubMed ID: 11721715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
    Mattiasson I; Rendell M; Törnquist C; Jeppsson S; Hulthén UL
    Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progestins and androgens.
    Whitehead M
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):161S-167S. PubMed ID: 7958012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC
    Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HRT and cardiovascular disease.
    Stevenson JC
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
    Shehata M; Kamel MA
    Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes.
    Masding MG; Stears AJ; Burdge GC; Wootton SA; Sandeman DD
    Diabet Med; 2006 Jul; 23(7):768-74. PubMed ID: 16842482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic effects of estrogens and progestins.
    LaRosa JC
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):140S-146S. PubMed ID: 7958008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
    Gaspard UJ
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):671-6. PubMed ID: 8991899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy: cardiovascular benefits for aging women.
    Sites CK
    Coron Artery Dis; 1998; 9(12):789-93. PubMed ID: 9894922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menopause and cardiovascular disease: the evidence.
    Rosano GM; Vitale C; Marazzi G; Volterrani M
    Climacteric; 2007 Feb; 10 Suppl 1():19-24. PubMed ID: 17364594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms whereby oestrogens influence arterial health.
    Stevenson JC
    Eur J Obstet Gynecol Reprod Biol; 1996 Mar; 65(1):39-42. PubMed ID: 8706955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Various actions of oestrogens on the vascular system.
    Stevenson JC
    Maturitas; 1998 Sep; 30(1):5-9. PubMed ID: 9819777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.